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The ErbB3/HER3 Intracellular Domain is Competent to Bind ATP and
Catalyze Autophosphorylation
Abstract
ErbB3/HER3 is one of four members of the human epidermal growth factor receptor (EGFR/HER) or ErbB
receptor tyrosine kinase family. ErbB3 binds neuregulins via its extracellular region and signals primarily by
heterodimerizing with ErbB2/HER2/Neu. A recently appreciated role for ErbB3 in resistance of tumor cells
to EGFR/ErbB2-targeted therapeutics has made it a focus of attention. However, efforts to inactivate ErbB3
therapeutically in parallel with other ErbB receptors are challenging because its intracellular kinase domain is
thought to be an inactive pseudokinase that lacks several key conserved (and catalytically important)
residues-including the catalytic base aspartate. We report here that, despite these sequence alterations, ErbB3
retains sufficient kinase activity to robustly trans-autophosphorylate its intracellular region--although it is
substantially less active than EGFR and does not phosphorylate exogenous peptides. The ErbB3 kinase
domain binds ATP with a K(d) of approximately 1.1 microM. We describe a crystal structure of ErbB3 kinase
bound to an ATP analogue, which resembles the inactive EGFR and ErbB4 kinase domains (but with a
shortened alphaC-helix). Whereas mutations that destabilize this configuration activate EGFR and ErbB4
(and promote EGFR-dependent lung cancers), a similar mutation conversely inactivates ErbB3. Using
quantum mechanics/molecular mechanics simulations, we delineate a reaction pathway for ErbB3-catalyzed
phosphoryl transfer that does not require the conserved catalytic base and can be catalyzed by the "inactive-
like" configuration observed crystallographically. These findings suggest that ErbB3 kinase activity within
receptor dimers may be crucial for signaling and could represent an important therapeutic target.
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SI Text
SI Materials and Methods. Modeling ErbB3 and EGF Receptor (EGFR)
Kinase Domains in Complex with Mg2þ-ATP and Substrate.Our model
for the tyrosine kinase domain (TKD) of ErbB3 in the inactive
conformation was constructed from the crystal structure of ErbB3
reported here and shown in Fig. 3A. The model for EGFR-TKD
in the active conformation was constructed from Protein Data
Bank (PDB) entry 1M14 (1). In addition, as a computational re-
ference we constructed a model for ErbB3 TKD in an active-like
conformation by homology modeling with the active EGFR-TKD
(PDB code 1M14) and ErbB4-TKD (PDB code 3BCE) as tem-
plates (1, 2). A sequence alignment between the TKDs of ErbB3,
EGFR, and ErbB4 was generated in MODELLER (3, 4) and was
used to generate an initial structure of active-like ErbB3-TKD by
using the coordinates of active EGFR and ErbB4 TKDs. Missing
residues were built by using the loop modeling algorithm in
MODELLER, and the structures were further refined by
performing additional energy minimization steps and assessed
for stereochemical quality by using PROCHECK (5).
Initial models of TKD ternary complexes with ATP, Mg2þ, and
a 7 amino acid substrate peptide were built on the basis of the
2GS6 crystal structure of EGFR-TKD with a bound bisubstrate
analogue of ATP and peptide (6), in which all components are
resolved. For ErbB3 (in inactive and active conformations) the
kinase structure was superposed on the 2GS6 complex by using
an rmsd-based alignment of Cα backbone atoms and a 7-residue
peptide (VPEYINQ) derived from the Y1068 site of the EGFR
C-terminal tail plus ATP were placed on the basis of rmsd
alignment with the bisubstrate analogue in 2GS6. Because the
transition state for the phosphoryl-transfer reaction in kinases
is believed to involve two divalent metal ions (Mg2þ) in the active
site, twoMg2þ ions were placed in complex with the kinase-bound
ATP on the basis of the 1ATP structure of protein kinase A
(active conformation of cAMP-dependent protein kinase or
PKA) (7).
System Preparation for Quantum Mechanics/Molecular Mechanics
(QM/MM) Simulations. Hydrogen atoms were added to the ternary
complex structures by using the HBUILD utility in CHARMM
(8). The protonation states of histidines were chosen according
to recommendations from the WHATIF web interface (http://
swift.cmbi.kun.nl). Protonation states for all titratable groups dis-
tal to the catalytic site were chosen as those expected in aqueous
solution on the basis of their individual pKa values (9). Given that
the protonation states of titratable side chains in the active site
can have considerable effect on the stability of the ground state as
well as on the energetics of the reaction landscape, the different
protonation states of the conserved aspartate D813 in EGFR,
proposed to function as a catalytic base, were evaluated by using
a Poisson–Boltzmann approach (10–12) to evaluate the relative
stabilities of unprotonated and protonated forms of the D813
side chain. Multiple protonation states of the conserved catalytic
aspartate (D831 in EGFR and D833 in ErbB3) were not consid-
ered because the location is relatively removed from the atoms
involved in the catalytic reaction pathway. Although recent stu-
dies of the Abl kinase have reported that the protonation state of
the corresponding aspartate is important in the flipping of the
Asp-Phe-Gly motif toward the active conformation (13), such
a flip for EGFR is already facilitated, even in the unprotonated
state for D831, by kinase dimerization (14). All models were ex-
plicitly solvated by using the 3-site (TIP3P) model for water (15),
and the buffering distance was set to 15 Å. Sodium (Naþ) and
chloride (Cl−) ions were added to achieve net electroneutrality
of the system and an ionic strength of 75 mM. All Naþ and
Cl− ions were placed at least 8 Å away from any protein atoms
and from each other. The ions were positioned at points of elec-
trostatic extrema by using a Debye–Huckel potential calculated at
300 K by using the program Solvate 1.0 (16). In order to prepare
the system for dynamics simulations, the solvated structures were
energy minimized by using a conjugate gradient algorithm to re-
move unfavorable contacts.
QM/MM Simulations. The QM/MM approach we adopted is based
on an existing interface between GAMESS-UK (17) and
CHARMM (8). The MM region was modeled by using the
CHARMM27 force-field parameters (18), and the wave function
optimizations in the QM region were performed by using electro-
nic density functional theory. For the quantum region, we chose
the two Mg2þ ions, water molecules within 5 Å of the Mg2þ ions,
segments of the ATP and the tyrosine substrate, and two catalytic
residues (D813 and D831 in EGFR; N815 and D833 in ErbB3),
yielding a total of 60 atoms for EGFR and 64 atoms for ErbB3,
including three link atoms each. In order to handle the phosphor-
ous chemistry reliably, the quantum region was treated by using
density functional theory with a Becke 3-parameter exchange,
Lee, Yang, and Parr exchange correlation function and a
6–31G* basis set (19), and the remaining protein and solvent
molecules were treated classically by using the CHARMM27
force field. Because the QM/MM boundary cuts across covalent
bonds, we applied the single link atom procedure (20) to satisfy
the valences of broken bonds in the QM region. The electrostatic
interactions between the quantum region and the classical atoms
belonging to groups at the QM/MM boundary were discarded,
because this choice has been shown to enhance the accuracy
in the resulting energies and geometries (21). We have extensively
explored this choice of the QM/MM region, including sensitivity
to the size of the QM region and the functional/basis set combi-
nation in our prior studies on closely related systems (22–24);
others have validated the choice of the link atom method (21).
Nonbonded van der Waals (VdW) interactions were treated by
applying a switching function at 10 Å and truncating the VdW
potential energy smoothly at a cutoff distance of 12 Å. The forces
in the quantum region were calculated on the fly, assuming that
the system moves on the Born–Oppenheimer surface defined by
the QM/MM Hamiltonian. The system was first subjected to
1,200 steps of the adopted basis Newton–Raphson minimization,
and subsequently QM/MM MD simulations were performed
during which the systems were first heated to 300 K and then
subjected to a constant temperature of 300 K dynamics using
a Langevin thermostat for 10 ps using a standard 1-fs time step
of integration.
Catalytic Reaction Pathways. The exact reaction coordinate is com-
plex and multi- (high) dimensional, and a quantitative estimate of
the free energy landscape cost can be obtained only by using
efficient long-time sampling approaches (25–29), which remain
prohibitively expensive for QM/MM applications because of large
computational cost. Although we believe that the true reaction
coordinate is complex, in the spirit of a recent study (30), we de-
scribe the reaction pathways in terms of several simple reaction
coordinates χ j. For phosphoryl transfer through the associative
mechanism, χ1 is the distance between the reactive tyrosyl oxygen
and the ATP γ-phosphate, χ2 is the distance between the tyrosyl
O- and ATP O2/3β, and χ3 is the ATP Pγ- ATP O2/3β distance.
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For phosphoryl transfer through dissociative mechanisms, in
addition to these three distances, χ4 includes the coordinate
for proton abstraction, namely, the distance between the tyrosyl
OH- and D830∶Oδ2. In order to drive the system along a reaction
coordinate, we performed restrained minimization as well as re-
strained sampling simulations by using the QM/MMHamiltonian
by augmenting the Hamiltonian in the ith window with a potential
bias term Σjwjð1∕2Þ × K × ðχ j − χi;0j Þ2; here, wj ¼ 0 or 1 is the
weight for χ j, K is the effective spring constant (ranging between
10 and 30 kcal · mol−1 · Å−2), and χi;0j are reference values for
sampling in different windows. Complete pathways were as-
sembled by varying offset distances χi;0j in increments of0.05 Å, where the positive and negative increments represent
the directionality of the energy scan. All reaction paths were ori-
ginated from configurations with tyrosine χ1 ¼ O-ATP Pγ dis-
tance of 3 Å (resulting from the classical umbrella sampling
described below) and computed by energy minimizations in
the presence of restraints and recalculating the single-point en-
ergies in the absence of the restraints. For our choice of the in-
crements of χi;0j , calculations performed in the forward and
reverse directions satisfied path reversibility in configurations
as well as energy values (see Fig. 4, main text). Following the en-
ergy scans, constant temperature restrained dynamics runs of
300 fs–1 ps for each window were also performed to ensure that
the reaction path was robust to thermal fluctuations (Fig. S5).
Sampling the Precatalytic Free Energy Landscape. The transition
state for the phosphoryl-transfer reaction is thought to involve
a trigonal-bipyramidal geometry stabilized by two divalent metal
ions in the active site and applicable to several kinases as well as
to DNA and RNA polymerases (31–33). Because the positions
and orientations of the ions and ATP relative to the substrate tyr-
osines in our initial modeled structures were determined either
from a bisubstrate ligand complex or by homology with protein
kinase A (see above), prior to QM/MM simulations we first ex-
plored the classical free energy landscape associated with posi-
tioning the nucleophilic oxygen on the tyrosine at a distance of
3 Å from the target phosphorous and appropriately positioned
relative to the catalytic Mg2þ ion in our models of EGFR and
ErbB3. We achieved this precatalytic sampling of conformational
space through classical umbrella sampling simulations, which en-
able the calculation of the potential of mean force (free energy
density) along an a priori chosen set of reaction coordinates from
which free energy changes are calculated by numerical integra-
tion (34). We mapped out the free energy landscape for preor-
ganizing the coordinate χ1 (the tyrosyl O-ATP Pγ distance) at
3 Å, in order to ensure uniformity across all models with respect
to the starting configuration in subsequent QM/MM simulations
of phosphoryl-transfer pathways. For computing the free energy
landscape, the probability distribution Pðχ1Þ is calculated by di-
viding χ1 into several (6 or 7) windows. The histograms for each
window are collected by harvesting classical molecular dynamics
trajectories of length 200 ps per window by using a harmonic
restraint 0.5 × K × ðχ1-χi;01 Þ2, χi;01 being the preset of the reaction
coordinate characterizing the ith sampling window, and
K ¼ 20 kcal · mol−1 · Å−2 being the force constant for the re-
straint along χ1. The sampling data from the different windows
are then processed by using the weighted histogram analysis
method (34); see Fig. S6.
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Fig. S1. (A) Dependence on divalent cation concentration of ErbB3-ICD autophosphorylation. Purified ErbB3-ICD665–1323 (3 μM) was incubated for 30 min in
100 mM MOPS pH 7, 150 mM NaCl, 5% glycerol, containing 1 mM ATP, 100 μM phospholipid (in vesicles) with 10% (mol/mol) DOGS-NTA-Ni, and the noted
concentrations of MnCl2 or MgCl2. Samples were subjected to SDS-PAGE and immunoblotting with antiphosphotyrosine antibodies. (B) Quantitation of 32P
incorporation into ErbB3-ICD by the kinase domains from ErbB3 or EGFR. A final concentration of 3 μMwild-type (histidine-tagged) ErbB3-TKD665–1001 or EGFR-
TKDwas coincubated with 6 μMhis6-ErbB3-ICD665–1323 (K723M) as substrate in 20mM Tris-HCl, pH 8.0, 200 mMNaCl, 5% glycerol, containing 0.1 mMDTT, 5 mM
MgCl2, 2 mM MnCl2, 100 μM ATP (with 3 μCi [γ-32P]-ATP) and 100 μM lipid (vesicles containing 10% DOGS-NTA-Niþ 90% DOPC). Reaction mixtures were
incubated at room temperature for the times listed, and reactions were stopped by adding EDTA to a final concentration of 50 mM. Samples were spotted
onto phosphocellulose paper to immobilize protein. After a series of washes, 32P incorporation was measured by scintillation counting. Mean range of
variation are plotted from at least two independent experiments. 32P incorporation catalyzed by ErbB3-TKD occurred at approximately 209 cpm per minute
(5,087 in 25 min; 10,698 in 50 min). 32P incorporation catalyzed by EGFR-TKD was clearly saturating (or depleting substrate) by 25min. On the basis of the 1-min
time point, we estimate a maximum incorporation rate of 198,575 cpm per minute, suggesting a rate that is ∼940-fold higher than that for ErbB3-TKD.
Fig. S2. Crystal packing of ErbB3-TKD665–1001. Cartoon representation of the ErbB3-TKD665–1001 structure, showingmajor crystal contacts. The green structure is
molecule A in the asymmetric unit, and the red structure is molecule B. These associate in the crystals through N-lobe-mediated interactions. In addition,
interaction partners in the crystal are shown for molecule B (Red) that associate through alternative N-lobe-mediated (Dark Blue) and C-lobe-mediated (Cyan)
contacts. The packing of ErbB3-TKD665–1001 molecules in our crystals appears to be the same as those recently described and discussed in detail by Jura et al. (35).
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Fig. S3. Mutating V836 in ErbB3-TKD648–1001 disrupts mant-ATP binding. Samples containing buffer alone or mutated ErbB3-TKD at 10 μM were incubated
alone (fourth set of bars), with 5 μMmant-ATP (third set of bars), with 5 μMmant-ATP plus 10 mMMgCl2 (first and second sets of bars), or with 5 μMmant-ATP,
10 mM MgCl2 plus 500 μM ATP (fifth set of bars). Assays were performed in 20 mM Tris pH 8.0, containing 200 mM NaCl, 5% glycerol. Fluorescence
measurements were taken in triplicate by using a Tecan SAFIRE II plate reader, with excitation wavelength of 340 nm and emission wavelength of
450 nm (10-nm bandwidth for both). The K723R mutant binds mant-ATP with an affinity similar to that seen for wild-type protein and shows a substantial
increase in fluorescence emission frommant-ATP that can be competed away by addition of excess ATP. By contrast, the V836Amutant displayed little evidence
of binding, consistent with the loss of the ability of V836A-mutated ErbB3-ICD to autophosphorylate as assessed in immunoblotting assays. Note that the first
and second sets of bars are experimental repeats.
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Fig. S4. Representative snapshots of intermediate states in the reaction pathway for phosphoryl transfer catalyzed by ErbB3-TKD in the inactive-like state.
States correspond to “R” (reactant); “TS” (transition state with trigonal-bipyramidal geometry around Pγ); “P” (product representing the completion of phos-
phoryl transfer with proton still bound to O1γ of ATP); and “P2” (product with proton transferred to O2β of ATP). The reaction pathway is characterized by
migration of the proton from the hydroxyl group of the tyrosine substrate to the Oγ1 oxygen of ATP (in TS) and its subsequent transfer to the Oβ2 atom of ATP
in P2. Phosphoryl transfer coincides with this proton transfer and occurs through an associative mechanism with characteristic values of 1.9 Å for the formation
and cleavage of bonds in the transition state (λa and λc in Fig. 4B, main text). No evidence was found in our simulations for proton transfer mediated
through N815—as expected. Thus, only pathway II in Fig. 4B (main text) ensues for ErbB3. Energy changes along the reaction pathway for ErbB3 (in the
structure described in this manuscript) are summarized in Fig. 4C, and states (R, TS, P, and P2) are marked. The activation energy (Ea) for the captured associative
mechanism of phosphoryl transfer is estimated to be 23 kcal∕mol (Fig. 4C).
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Fig. S5. (Upper) Normalized histograms representing the distributions of values for the distances between the proton of the substrate tyrosine hydroxyl and
(A) the Oδ2 oxygen of D813 in EGFR or equivalent in ErbB3 (δI) or (B) the O1γ oxygen of ATP (δII ) recorded in our simulations of the ground state (reactant)
dynamics for EGFR (Blue) and ErbB3 (Red). For EGFR, the proton of the substrate tyrosine hydroxyl is primed for transfer to two positions that are mutually
exclusive: (1) through hydrogen bonding to the Oδ2 atom of D813, indicated by the small value of δI ; and (2) through hydrogen bonding to the O1γ oxygen of
ATP, indicated by the small δII value. The bimodal distribution of δI and δII values for EGFR (Blue) serves to select either of the two competing routes labeled as
pathways I and II in Fig. 4A (main text) for proton transfer and concomitant phosphoryl transfer. By contrast, with N815 in ErbB3 replacing the EGFR catalytic
base (D813), δI for ErbB3 remains ≥3.5 Å (Red), suggesting no proton transfer (via pathway I) to N815. Thus, the distribution of ErbB3 δI and δII values serve to
select only one pathway, namely, pathway II in Fig. 4B, with proton transfer exclusively to the ATP O1γ oxygen for this kinase. (Lower) Distributions of values for
the nucleophilic attack distance, λa (distance between the tyrosine oxygen and the ATP Pγ) and the bond cleavage distance, λc (distance between the ATP Pγ and
ATP O2/3β) along the reaction pathways for EGFR (Blue; C, D, and F) and ErbB3 (Red; E). R ¼ reactant; P ¼ product; and TS ¼ transition state characterized by a
trigonal-bipyramidal geometry about Pγ. For pathway I (only detected in EGFR simulations), phosphoryl transfer proceeds concomitant with migration of the
proton from the tyrosine hydroxyl group to the D813 Oδ2 oxygen and occurs through either a dissociative (C) or associative (D) mechanism. The hallmark of a
dissociative mechanism is that the sum of λa and λc in the transition state is greater than the corresponding sum in the reactant and product states, as seen in C,
where the TS region lies above the line that joins the R and P states in a λa versus λc plot. By contrast, in the associative mechanism (D), λa þ λc in the transition
state is less than seen for the R or P states and lies below the line connecting R and P. By contrast, for pathway II (with proton transfer from tyrosine -OH to ATP
O1γ) concomitant phosphoryl transfer occurs only through an associative mechanism in our simulations for ErbB3 in an active-like configuration (E) and EGFR
(F), with the TS lying below the line joining the R and P states in the λa versus λc plots.
Fig. S6. Free energy landscape for preorganizing the nucleophilic attack distance χ1 ¼ λa from the ground state to a state where χ1 ¼ 3 Å in the EGFR (Top)
and ErbB3 TKD (Bottom) systems, on the basis of classical umbrella sampling simulations. Starting from the ground state of the TKD/ATP/substrate ternary
complex as obtained from energy minimizations of our model structures (see SI Materials and Methods), the free energy change to reach χ1 ¼ 3 Å is 3.5kBT
(2 kcal∕mol) for EGFR and 6kBT (3.5 kcal∕mol) for ErbB3. Executing this minimization step ensures uniformity in reactant states across all systems prior to the
QM/MM simulations described here.
Shi et al. www.pnas.org/cgi/doi/10.1073/pnas.1002753107 5 of 6
ErbB3-ICD665-1323 + ErbB3-TKD
α-pTyr
α-His5
A
ErbB3-ICD665-1323 + EGFR-TKD
-
- -
+ + + +
L G E
ATP
Inhibitor
B
-
- -
+ + + +
L G E
ATP
Inhibitor
α-pTyr
α-His5
Fig. S7. Western blot analysis to assess the effect of EGFR or EGFR/ErbB2 inhibitors on (A) ErbB3-TKD activity and (B) EGFR-TKD activity. Phosphorylation of
ErbB3-ICD665–1323 was monitored byWestern blotting with antiphosphotyrosine antibodies. ErbB3-ICD665–1323 (0.3 μM) was mixed with 0.3 μM ErbB3-TKD (A) or
0.3 μM EGFR-TKD (B) in 20 mM Tris-HCl, pH8.0, 200 mM NaCl, 5% glycerol, 0.1 mM DTT, 5 mM MgCl2, 2 mM MnCl2, 100 μM ATP, and 10 μM lipid
(10%NTA-NiDOGSþ 90%DOPC in vesicles) for 1 hr (A) or 1 min (B) at 25 °C. Samples were then subjected to immunoblotting with pY20 antiphosphotyrosine
(Upper) and anti-His5 antibody for normalization (Lower). Experiments were performed with and without ATP. To assess inhibitor specificity, experiments were
performed in the presence of 4 μM lapatinib (L), 4 μM gefitinib (G), 4 μM erlotinib (E), or without inhibitor (DMSO only: “-”). All three inhibitors blocked EGFR
activity, but left trans-phosphorylation by ErbB3-TKD unaffected. Blots are representative of at least 3 independent experiments.
Table S1. Data collection and refinement statistics (molecular replacement)
ErbB3 TKD
Data collection APS (GM/CA CAT)
Space group C2
Cell dimensions
a, b, c (Å), β (°) 193.4, 48.0, 82.2, β ¼ 108.1°
Resolution (Å) 50.00-2.80 (2.85–2.80)*
Rsym or Rmerge 0.083 (0.499)
I∕σI 17.1 (2.2)
Completeness (%) 90.0 (55.3)
Redundancy 6.3 (3.4)
Refinement
Resolution (Å) 50.00-2.80
No. reflections 14,406
Rwork∕Rfree 25.2/28.5
Model
Protein amino acids aa A680–728, 732–844, 854–959 aa B680–711, 713–729, 732–845, 854–959
No. atoms 4,316
Protein 4,245
Ligand/ion 64
Water 7
rmsd
Bond lengths (Å) 0.006
Bond angles (°) 1.099
*Values in parentheses are for highest-resolution shell.
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